000 01593 a2200469 4500
005 20250513203039.0
264 0 _c20000307
008 200003s 0 0 eng d
022 _a0277-3732
024 7 _a10.1097/00000421-200002000-00014
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWeng, E
245 0 0 _aAccuracy and clinical impact of mediastinal lymph node staging with FDG-PET imaging in potentially resectable lung cancer.
_h[electronic resource]
260 _bAmerican journal of clinical oncology
_cFeb 2000
300 _a47-52 p.
_bdigital
500 _aPublication Type: Clinical Trial; Comparative Study; Journal Article
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aFluorodeoxyglucose F18
650 0 4 _aHumans
650 0 4 _aLung Neoplasms
_xpathology
650 0 4 _aLymphatic Metastasis
_xdiagnostic imaging
650 0 4 _aMediastinal Neoplasms
_xdiagnostic imaging
650 0 4 _aMiddle Aged
650 0 4 _aNeoplasm Staging
650 0 4 _aRadiopharmaceuticals
650 0 4 _aRetrospective Studies
650 0 4 _aSensitivity and Specificity
650 0 4 _aTomography, Emission-Computed
650 0 4 _aTomography, X-Ray Computed
700 1 _aTran, L
700 1 _aRege, S
700 1 _aSafa, A
700 1 _aSadeghi, A
700 1 _aJuillard, G
700 1 _aMark, R
700 1 _aSantiago, S
700 1 _aBrown, C
700 1 _aMandelkern, M
773 0 _tAmerican journal of clinical oncology
_gvol. 23
_gno. 1
_gp. 47-52
856 4 0 _uhttps://doi.org/10.1097/00000421-200002000-00014
_zAvailable from publisher's website
999 _c10637362
_d10637362